skip to Main Content
Menu

Oncology Clinical Development Challenges & Opportunities in the Phase I Setting

This article provides a brief overview of targeted cancer therapy and discusses certain challenges to their development, as they relate to the Phase I clinical development setting.

This article provides a brief overview of targeted cancer therapy and discusses certain challenges to their development, as they relate to the Phase I clinical development setting.

In addition, a unique concept developed by Scimega Research, called the Reverse Feasibilityâ„¢ Program, is explained to demonstrate opportunities that exist to support the efforts of both industry and clinicians.

What are your thoughts on this topic? Join the discussion in the Optimizing Oncology Clinical Research group on LinkedIn.

VIEW THE ARTICLE

Sign up to
Canadian Oncology
Trial News

  • This field is for validation purposes and should be left unchanged.
Back To Top
×Close search
Search